Our observations confirmed that after glioblastoma cells were treated with 4MU for 48 h, the expression level of CD47 was significantly reduced, and this inhibitory effect was reversed by exogenous HA (Fig. 6A, C). The gene discussed is CD47; the disease is glioblastoma.